Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology.

× No keyword cloud information.

88 in total

1. Development of an experimental protocol for uptake studies of metal compounds in adherent tumor cells.

Authors: Alexander E Egger; Christina Rappel; Michael A Jakupec; Christian G Hartinger; Petra Heffeter; Bernhard K Keppler
Journal: J Anal At Spectrom Date: 2009-01 Impact factor: 4.023

2. Antimicrobial Activity and DNA/BSA Binding Affinity of Polynuclear Silver(I) Complexes with 1,2-Bis(4-pyridyl)ethane/ethene as Bridging Ligands.

Authors: Sonja Ž Đurić; Sandra Vojnovic; Tina P Andrejević; Nevena Lj Stevanović; Nada D Savić; Jasmina Nikodinovic-Runic; Biljana Đ Glišić; Miloš I Djuran
Journal: Bioinorg Chem Appl Date: 2020-04-14 Impact factor: 7.778

3. X-ray absorption spectroscopy studies of the adducts formed between cytotoxic gold compounds and two major serum proteins.

Authors: L Messori; A Balerna; I Ascone; C Castellano; C Gabbiani; A Casini; C Marchioni; G Jaouen; A Congiu Castellano
Journal: J Biol Inorg Chem Date: 2010-12-24 Impact factor: 3.358

4. High in Vitro and in Vivo Tumor-Selective Novel Ruthenium(II) Complexes with 3-(2'-Benzimidazolyl)-7-fluoro-coumarin.

Authors: Qi-Pin Qin; Zhen-Feng Wang; Xiao-Ling Huang; Ming-Xiong Tan; Bei-Bei Shi; Hong Liang
Journal: ACS Med Chem Lett Date: 2019-05-22 Impact factor: 4.345

5. Pre-association of polynuclear platinum anticancer agents on a protein, human serum albumin. Implications for drug design.

Authors: Eva I Montero; Brad T Benedetti; John B Mangrum; Michael J Oehlsen; Yun Qu; Nicholas P Farrell
Journal: Dalton Trans Date: 2007-10-02 Impact factor: 4.390

6. Exploring metallodrug-protein interactions by mass spectrometry: comparisons between platinum coordination complexes and an organometallic ruthenium compound.

Authors: Angela Casini; Chiara Gabbiani; Elena Michelucci; Giuseppe Pieraccini; Gloriano Moneti; Paul J Dyson; Luigi Messori
Journal: J Biol Inorg Chem Date: 2009-03-14 Impact factor: 3.358

7. Transferring the concept of multinuclearity to ruthenium complexes for improvement of anticancer activity.

Authors: Maria G Mendoza-Ferri; Christian G Hartinger; Marco A Mendoza; Michael Groessl; Alexander E Egger; Rene E Eichinger; John B Mangrum; Nicholas P Farrell; Magdalena Maruszak; Patrick J Bednarski; Franz Klein; Michael A Jakupec; Alexey A Nazarov; Kay Severin; Bernhard K Keppler
Journal: J Med Chem Date: 2009-02-26 Impact factor: 7.446

8. Luminescent iminophosphorane gold, palladium and platinum complexes as potential anticancer agents.

Authors: Malgorzata Frik; Josefina Jiménez; Vadim Vasilevski; Monica Carreira; Andreia de Almeida; Elena Gascón; Farrah Benoit; Mercedes Sanaú; Angela Casini; María Contel
Journal: Inorg Chem Front Date: 2014-03-07 Impact factor: 6.569

9. Synthesis of apoptosis-inducing iminophosphorane organogold(III) complexes and study of their interactions with biomolecular targets.

Authors: Neha Shaik; Alberto Martínez; Idline Augustin; Hugh Giovinazzo; Armando Varela-Ramírez; Mercedes Sanaú; Renato J Aguilera; María Contel
Journal: Inorg Chem Date: 2009-02-16 Impact factor: 5.165

10. In vitro cytotoxic activity of tri-n-butyltin(IV)lupinylsulfide hydrogen fumarate (IST-FS 35) and preliminary antitumor activity in vivo.

Authors: Angela Alama; Maurizio Viale; Michele Cilli; Cristina Bruzzo; Federica Novelli; Bruno Tasso; Fabio Sparatore
Journal: Invest New Drugs Date: 2008-06-19 Impact factor: 3.850